Metoclopramide for Preventing Ileus after Benign Gynecologic Surgery: A randomized controlled trial
Thai Journal of Obstetrics and Gynaecology · 01.01.2023
DOI: 10.14456/tjog.2023.23 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Thai Journal of Obstetrics and Gynaecology, erschienen am 01.01.2023. Verfasst von Chainarong Sillapasa.
Abstract (Originalsprache)
Objective
To assess the efficacy of metoclopramide for preventing ileus after benign gynecologic surgery Materials and Methods: The included participants were diagnosed with benign gynecologic conditions and scheduled for abdominal hysterectomy at Khon Kaen Hospital between October 2021 and May 2022. The participants were randomly allocated into two groups: the metoclopramide group (n=25) received an injection of 2 ml (10 mg) of intramuscular metoclopramide, while the control group (n=25) received an injection of 2 ml of intramuscular normal saline at 2 h after surgery.
Results
The metoclopramide group had significantly less time to first passage of flatus than the control (placebo) group (1,785.3 ± 125.7 vs. 2,186.3 ± 103.0 min, mean difference 401.0 min (95% CI 73.1 to 728.9, p=0.02)). The incidence of ileus symptoms was significantly less in the metoclopramide group than in the control group (28% vs. 68%, p
Schlagwörter
Zitieren
APA
Sillapasa, C. (2023). Metoclopramide for Preventing Ileus after Benign Gynecologic Surgery: A randomized controlled trial. Thai Journal of Obstetrics and Gynaecology. https://doi.org/10.14456/tjog.2023.23
Vancouver
Sillapasa C. Metoclopramide for Preventing Ileus after Benign Gynecologic Surgery: A randomized controlled trial. Thai Journal of Obstetrics and Gynaecology. 2023. doi:10.14456/tjog.2023.23
BibTeX
@article{Sillapasa2023,
author = {Sillapasa, Chainarong},
title = {Metoclopramide for Preventing Ileus after Benign Gynecologic Surgery: A randomized controlled trial},
journal = {Thai Journal of Obstetrics and Gynaecology},
year = {2023},
doi = {10.14456/tjog.2023.23}
}
EUVIMED